{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T10:35:38Z","timestamp":1777286138210,"version":"3.51.4"},"reference-count":25,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,12,10]],"date-time":"2019-12-10T00:00:00Z","timestamp":1575936000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100011202","name":"FP7 Research for the Benefit of SMEs","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100011202","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010269","name":"Wellcome Trust","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010269","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["EBioMedicine"],"published-print":{"date-parts":[[2020,2]]},"DOI":"10.1016\/j.ebiom.2019.102601","type":"journal-article","created":{"date-parts":[[2020,1,14]],"date-time":"2020-01-14T18:57:35Z","timestamp":1579028255000},"page":"102601","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"special_numbering":"C","title":["Pharmacokinetics of TKM-130803\u00a0in Sierra Leonean patients with\u00a0Ebola virus disease: \u00a0plasma concentrations exceed target levels, with\u00a0drug\u00a0accumulation in the most severe patients"],"prefix":"10.1016","volume":"52","author":[{"given":"Janet T.","family":"Scott","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raman","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luke W.","family":"Meredith","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jake","family":"Dunning","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Catrin E.","family":"Moore","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Foday","family":"Sahr","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Steve","family":"Ward","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ian","family":"Goodfellow","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"Horby","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.ebiom.2019.102601_bib0001","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1001997","article-title":"Experimental treatment of Ebola virus disease with TKM-130803: a single-arm phase 2 clinical trial","volume":"13","author":"Dunning","year":"2016","journal-title":"PLoS Med"},{"issue":"9","key":"10.1016\/j.ebiom.2019.102601_bib0002","doi-asserted-by":"crossref","first-page":"E280","DOI":"10.1016\/S1473-3099(17)30234-7","article-title":"Insights from clinical research completed during the west Africa Ebola virus disease epidemic","volume":"17","author":"Rojek","year":"2017","journal-title":"Lancet Infect Dis"},{"issue":"8","key":"10.1016\/j.ebiom.2019.102601_bib0003","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1007\/s40262-015-0364-1","article-title":"Ebola virus infection: review of the pharmacokinetic and pharmacodynamic properties of drugs considered for testing in human efficacy trials","volume":"55","author":"Madelain","year":"2016","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.ebiom.2019.102601_bib0004","doi-asserted-by":"crossref","unstructured":"Mirza M, Vanmeert, M, Ali, A, Kanzal, I, Froeyen, M, Idrees, M. Perspectives towards antiviral drug dicovery against ebola virus. Journal of medical virology 2018.","DOI":"10.1002\/jmv.25357"},{"issue":"9729","key":"10.1016\/j.ebiom.2019.102601_bib0005","doi-asserted-by":"crossref","first-page":"1896","DOI":"10.1016\/S0140-6736(10)60357-1","article-title":"Postexposure protection of non-human primates against a lethal ebola virus challenge with RNA interference: a proof-of-concept study","volume":"375","author":"Geisbert","year":"2010","journal-title":"Lancet"},{"issue":"7552","key":"10.1016\/j.ebiom.2019.102601_bib0006","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1038\/nature14442","article-title":"Lipid nanoparticle siRNA treatment of ebola-virus-makona-infected nonhuman primates","volume":"521","author":"Thi","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.ebiom.2019.102601_bib0007","first-page":"29","article-title":"Post-exposure treatments for ebola and marburg virus infections","volume":"29","author":"Cross","year":"2018","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.ebiom.2019.102601_bib0008","unstructured":"Interim assessment report Review under Article 5(3) of Regulation (EC) No 726\/2004 Medicinal products under development for the treatment of Ebola. Committee for Medicinal Products for Human Use (CHMP); 2015. Contract No.: Procedure no: EMEA\/H\/A-5(3)\/1410."},{"issue":"4","key":"10.1016\/j.ebiom.2019.102601_bib0009","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1093\/cid\/civ334","article-title":"The use of TKM-100802 and convalescent plasma in 2 patients with ebola virus disease in the united states","volume":"61","author":"Kraft","year":"2015","journal-title":"Clin Infect Dis"},{"issue":"5","key":"10.1016\/j.ebiom.2019.102601_bib0010","doi-asserted-by":"crossref","first-page":"954","DOI":"10.4269\/ajtmh.2010.09-0636","article-title":"Comprehensive panel of real-time taqman\u2122 polymerase chain reaction assays for detection and absolute quantification of filoviruses, arenaviruses, and new world hantaviruses","volume":"82","author":"Trombley","year":"2010","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.ebiom.2019.102601_bib0011","unstructured":"Warren TK. In vitro efficacy of TKM-100802 against Ebola virus in human HepG2 cells \u2013 EC50 and therapeutic index. Report No. TEKIV001. USAMRIID 2013."},{"issue":"4","key":"10.1016\/j.ebiom.2019.102601_bib0012","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1097\/FTD.0b013e31825c4ba6","article-title":"Accurate detection of outliers and subpopulations with pmetrics, a nonparametric and parametric pharmacometric modeling and simulation package for R","volume":"34","author":"Neely","year":"2012","journal-title":"Ther Drug Monit"},{"issue":"10","key":"10.1016\/j.ebiom.2019.102601_bib0013","doi-asserted-by":"crossref","first-page":"2854","DOI":"10.1093\/jac\/dkv173","article-title":"Plasma and peritoneal fluid population pharmacokinetics of micafungin in post-surgical patients with severe peritonitis","volume":"70","author":"Grau","year":"2015","journal-title":"J Antimicrob Chemother"},{"issue":"5","key":"10.1016\/j.ebiom.2019.102601_bib0014","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1093\/jac\/dku564","article-title":"Plasma and target-site subcutaneous tissue population pharmacokinetics and dosing simulations of cefazolin in post-trauma critically ill patients","volume":"70","author":"Roberts","year":"2015","journal-title":"J Antimicrob Chemother"},{"issue":"10","key":"10.1016\/j.ebiom.2019.102601_bib0015","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1038\/nmicrobiol.2016.142","article-title":"Rescue of non-human primates from advanced Sudan ebolavirus infection with lipid encapsulated siRNA","volume":"1","author":"Thi","year":"2016","journal-title":"Nat Microbiol"},{"key":"10.1016\/j.ebiom.2019.102601_bib0016","unstructured":"WHO. Ebola Virus Disease. WHO Fact Sheet 2018."},{"issue":"1","key":"10.1016\/j.ebiom.2019.102601_bib0017","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1177\/1740774515617740","article-title":"Trial design for evaluating novel treatments during an outbreak of an infectious disease","volume":"13","author":"Whitehead","year":"2016","journal-title":"Clin Trials"},{"issue":"9","key":"10.1016\/j.ebiom.2019.102601_bib0018","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0162199","article-title":"Experimental treatment of ebola virus disease with brincidofovir","volume":"11","author":"Dunning","year":"2016","journal-title":"PLoS ONE"},{"issue":"2","key":"10.1016\/j.ebiom.2019.102601_bib0019","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1371\/journal.pntd.0005389","article-title":"Favipiravir pharmacokinetics in ebola-infected patients of the JIKI trial reveals concentrations lower than targeted","volume":"11","author":"Nguyen","year":"2017","journal-title":"PLoS Negl Trop Dis"},{"issue":"10174","key":"10.1016\/j.ebiom.2019.102601_bib0020","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1016\/S0140-6736(18)33132-5","article-title":"Ebola virus disease","volume":"393","author":"Malvy","year":"2019","journal-title":"Lancet"},{"issue":"12","key":"10.1016\/j.ebiom.2019.102601_bib0021","doi-asserted-by":"crossref","first-page":"4421","DOI":"10.1172\/JCI83162","article-title":"Ebola viral load at diagnosis associates with patient outcome and outbreak evolution","volume":"125","author":"de La Vega","year":"2015","journal-title":"J Clin Investig"},{"key":"10.1016\/j.ebiom.2019.102601_bib0022","unstructured":"Corporation TP. Investigator's Brochure, TKM -100802 for Injection (Formerly TKM-100201 Injection): TKM-Ebola."},{"issue":"12","key":"10.1016\/j.ebiom.2019.102601_bib0023","doi-asserted-by":"crossref","first-page":"2120","DOI":"10.3201\/eid2212.161136","article-title":"Electrolyte and metabolic disturbances in ebola patients during a clinical trial, guinea, 2015","volume":"22","author":"van Griensven","year":"2016","journal-title":"Emerg Infect Dis"},{"issue":"22","key":"10.1016\/j.ebiom.2019.102601_bib0024","doi-asserted-by":"crossref","first-page":"2092","DOI":"10.1056\/NEJMoa1411680","article-title":"Clinical illness and outcomes in patients with ebola in sierra leone","volume":"371","author":"Schieffelin","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ebiom.2019.102601_bib0025","unstructured":"WHO. Situation Report Ebola Virus Disease 2016."}],"container-title":["EBioMedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352396419308163?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352396419308163?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T18:55:33Z","timestamp":1762455333000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352396419308163"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2]]},"references-count":25,"alternative-id":["S2352396419308163"],"URL":"https:\/\/doi.org\/10.1016\/j.ebiom.2019.102601","relation":{},"ISSN":["2352-3964"],"issn-type":[{"value":"2352-3964","type":"print"}],"subject":[],"published":{"date-parts":[[2020,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pharmacokinetics of TKM-130803\u00a0in Sierra Leonean patients with\u00a0Ebola virus disease: \u00a0plasma concentrations exceed target levels, with\u00a0drug\u00a0accumulation in the most severe patients","name":"articletitle","label":"Article Title"},{"value":"EBioMedicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ebiom.2019.102601","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"102601"}}